September 25–27, 2025
Cambridge, MA

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

7
The CMT Research Foundation unites the voices of patients, researchers, pharma companies, and regulatory agencies to develop treatments for CMT.
This event takes place over three days. Thursday and Friday are scientific meetings meant for researchers and scientists working in CMT. Saturday is primarily for patients and their families and caregivers, providing a chance to interact with the research community that is working so hard on their behalf and to better understand the latest in research progress.

For the Scientific Community

September 25-26th

Two days for researchers, industry and government agencies to:

  • SHARE the latest in CMT drug development research
  • CREATE new connections and collaborations
  • EXAMINE the most pressing issues facing CMT drug development

For the Patient Community

September 27th

A day for the patient community to:

  • LEARN about the latest developments and clinical trials in CMT
  • INTERACT with distinguished scientific experts and clinicians
  • ACT to speed treatments for patients and families

Thank you to our 2024 Sponsors!

Accelerant Sponsor

Patient Day Sponsors

Research Lunch Sponsor

Supporting Sponsors

Family Sponsor

The Scientific Programming Committee

Afrooz Rashnonejad, MSc, PhD, Co-Chair

Principal Investigator, Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children’s Hospital
Assistant Professor, Department of Pediatrics, The Ohio State University College of Medicine

Brett McCray, MD, PhD, Co-Chair

Assistant Professor of Neurology
University of Michigan

Charles Abrams, MD, PhD

Professor of Neurology and Rehabilitation
University of Illinois, Chicago

Stephan Zuchner, MD, PhD, FANN

Professor of Human Genetics and Neurology
University of Miami Miller School of Medicine

Rob Burgess, PhD

Professor
The Jackson Laboratory